Roivant (ROIV) Director Melissa Epperly Receives 543-Share Award

What Happened

• Melissa B. Epperly, a director of Roivant Sciences Ltd. (ROIV), was issued 543 common shares on July 17, 2026 as an award/grant. The Form 4 reports the shares were acquired at $0.00 (total reported value $0) under an award code A.

Key Details

• Transaction date: 2026-07-17; Form 4 filed: 2026-07-21 (filed within the required two-business-day window).
• Amount: 543 shares; price reported: $0.00; reported total value: $0.
• Shares owned after the transaction: not specified in the filing.
• Footnote: F1 states these shares were issued under the issuer’s Non-Employee Director Compensation Plan and were fully vested as of the grant date.
• Filing includes Exhibit 24 (Power of Attorney).

Context

• This was a compensation award to a non-employee director (not an open-market purchase or sale). Because the award was fully vested and issued at no cash cost, it reflects director compensation rather than a market-based buy or sell signal.